HOME
MARKET
TRADE
PRICING
PLATFORM
HELP
LOG IN
BioMarin Says Valoctocogene Roxaparvovec On Track For US, EU Regulatory Submission By End Of 2019
Benzinga · 11/14/2019 16:03
Related